Home
Andrew J. Schwab, 10% Owner: Enliven Therapeutics ELVN Sell · Filed 23/09/28
Trade details
- Type
- Insider sale
- Amount
- $2,471,835
- Shares · price
- 164,789 sh · $15.00 a share
- Held after
- 4,306,179 sh
- Trade date
- 23/09/26
- Filed
- 23/09/28
- Days to filing
- 2 days
Sold 3.7% of holdings
- Share of holding sold
- 3.7%
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 23/08/27~23/10/26Andrew J. Schwab's recent trades
- Andrew J. Schwab
SellSkye Bioscience
SellSkye Bioscience
SKYE
$184.9K
114,851 sh
$184.9K
Filed 09/24
Traded 09/23
- Andrew J. Schwab
SellSkye Bioscience
SellSkye Bioscience
SKYE
$45.6K
27,612 sh
$45.6K
Filed 09/24
Traded 09/22
- Andrew J. Schwab
SellSkye Bioscience
SellSkye Bioscience
SKYE
$7,290
4,528 sh
$7,290
Filed 09/24
Traded 09/23
- Andrew J. Schwab
SellSkye Bioscience
SellSkye Bioscience
SKYE
$1,795
1,088 sh
$1,795
Filed 09/24
Traded 09/22
- Andrew J. Schwab
SellEntrada Therapeutics
SellEntrada Therapeutics
TRDA
$1.8M
200,000 sh
$1.8M
Filed 25/11/18
Traded 25/11/14
